首页 | 官方网站   微博 | 高级检索  
     

血清核仁素检测在结肠癌中的临床应用
引用本文:王晓明,卢小东,严 枫,万 杰,莫冬萍.血清核仁素检测在结肠癌中的临床应用[J].南京医科大学学报,2016(5):529-532.
作者姓名:王晓明  卢小东  严 枫  万 杰  莫冬萍
作者单位:江苏大学医学院组织胚胎学教研室,江苏 镇江 212013; 南京医科大学附属肿瘤医院检验科,江苏 南京 210009,江苏大学医学院组织胚胎学教研室,江苏 镇江 212013,南京医科大学附属肿瘤医院检验科,江苏 南京 210009,南京医科大学附属肿瘤医院检验科,江苏 南京 210009,南京医科大学附属肿瘤医院检验科,江苏 南京 210009
基金项目:国家自然科学基金(21475063)
摘    要:目的:探讨核仁素(nucleolin)在结肠癌患者血清中的水平与临床意义?方法:用酶联免疫吸附实验(ELISA)法检测172例结肠癌患者?24例直肠癌患者和80例健康体检者血清中核仁素含量,并分析血清核仁素水平与结肠癌患者临床病理特征之间的关系?结果:结肠癌患者血清中核仁素含量为(228.9 ± 212.4)pg/mL,直肠癌患者为(115.1 ± 34.5)pg/mL,健康对照组为(101.13 ± 32.4)pg/mL?结肠癌患者血清核仁素水平明显高于健康对照组(P < 0.001),直肠癌患者与健康对照组间差异无统计学意义(P > 0.05)?在结肠癌检测中,血清核仁素敏感性为91.9%?特异性为83.8%,癌胚抗原(carcino-embryonic antigen,CEA)敏感性为68.6%?特异性为85.0%?浸润型结肠癌患者中血清核仁素水平明显高于隆起型和溃疡型(P < 0.05)?结肠癌患者血清核仁素水平与年龄?性别?肿瘤大小?分化程度?浸润程度?淋巴结转移?远处转移?TNM分期?Ducks分期均无相关性(P均 > 0.05)?结论:结肠癌患者血清核仁素检测敏感性和特异性较高,敏感性优于CEA,特异性与CEA相当,对结肠癌的诊断有潜在应用价值?

关 键 词:核仁素  肠癌  血清
收稿时间:1/7/2016 12:00:00 AM

Expression of serum nucleolin and its clinical relevance in colorectal cancer
Wang Xiaoming,Lu Xiaodong,Yan Feng,Wan Jie and Mo Dongping.Expression of serum nucleolin and its clinical relevance in colorectal cancer[J].Acta Universitatis Medicinalis Nanjing,2016(5):529-532.
Authors:Wang Xiaoming  Lu Xiaodong  Yan Feng  Wan Jie and Mo Dongping
Affiliation:Department of Histology and Embryology,School of Medicine,Jiangsu University,Zhenjiang 212013; Clinical Laboratory,Cancer Hospital Affiliated to NJMU,Nanjing 210009,China,Department of Histology and Embryology,School of Medicine,Jiangsu University,Zhenjiang 212013,Clinical Laboratory,Cancer Hospital Affiliated to NJMU,Nanjing 210009,China,Clinical Laboratory,Cancer Hospital Affiliated to NJMU,Nanjing 210009,China and Clinical Laboratory,Cancer Hospital Affiliated to NJMU,Nanjing 210009,China
Abstract:Objective:To investigate the level of nucleolin in serum of colorectal cancer patients and its clinical significance. Methods:The levels of serum nucleolin in 172 patients with colon cancer,24 patients with rectal cancer and 80 healthy controls were determined by enzyme linked immunosorbent assay (ELISA). The relationship between serum nucleolin level in colon cancer and clinical features and pathological features were analyzed. Results:The serum nucleolin level in colon cancer patients,rectal cancer patients,and healthy controls were 228.9 ± 212.4 pg/mL,115.1 ± 34.5 pg/mL and 101.1 ± 32.4 pg/mL. The serum nucleolin level in colon cancer patients was significantly higher than that in healthy controls (P < 0.001),and there was no significantly difference between rectal cancer patients and healthy controls (P > 0.05). The sensitivity and specificity of serum nucleolin detecting in colon cancer were 91.9% and 83.8%,and serum carcino-embryonic antigen (CEA)were 68.6%,85.0%,respectively. The level of nucleolin in serum of infiltrating type colorectal cancer was significantly higher than that in protruded type and ulcerative type (P < 0.05). There was no correlation with the serum nucleolin level in colon cancer and age,gender,tumor size,differentiation degree,degree of invasion,lymph node metastasis,distant metastasis,TNM stage,and Ducks stage. Conclusion:The detection of serum nucleolin level in colon cancer patients has a high sensitivity and specificity,and the sensitivity is better than CEA and the specificity is as similer as CEA. Serum nucleolin may be potential valuable for colon cancer diagnosis.
Keywords:nucleolin  colorectal cancer  serum
点击此处可从《南京医科大学学报》浏览原始摘要信息
点击此处可从《南京医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号